DEA-Compliant Pharmaceutical Reverse Distribution & Credit Processing

This contract involves providing DEA-registered reverse distribution services for pharmaceuticals, specifically focusing on the receipt, processing, and return of eligible drugs to manufacturers. The contractor must ensure that all credits for returned pharmaceuticals are applied within a 120-day period. The solicitation is a subcontract opportunity under the NAICS code 424210 and is designated as an Indian Small Business Economic Enterprise (ISBEE) set-aside, indicating it is tailored for businesses affiliated with the Department of Interior and Indian Health Services. The contract is issued by the Billings Area Indian Health Service, part of the Department of Health and Human Services. The contract was posted on June 1, 2026, with a response deadline of June 8, 2026. It requires strict compliance with DEA regulations related to pharmaceutical reverse distribution and credit processing. Although specific location details for performance and points of contact are not provided, businesses fitting the ISBEE eligibility and holding the necessary DEA registration for reverse distribution are targeted. This contract supports the management and redistribution of pharmaceuticals within the Indian Health Services framework, ensuring regulatory compliance and timely financial reconciliation.